Asthma between 2 and 5 years: a key period

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 46, Issue 6, 2006, Pages 560-565

  Gotz M ^a  

^a WILHELMINEN HOSPITAL   (Austria)

Author keywords

Asthma background; Pharmacotherapy; Preschool asthma

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; MONTELUKAST; OMALIZUMAB; SALBUTAMOL; SHORT ACTING DRUG; TERBUTALINE; THEOPHYLLINE;

AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; ALLERGY TEST; ARTICLE; CHILD NUTRITION; CHILDHOOD DISEASE; DIZZINESS; DRUG ERUPTION; DRUG INDUCED HEADACHE; ENVIRONMENTAL FACTOR; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HEREDITY; HUMAN; IMMUNOTHERAPY; INFECTION RISK; LUNG CLEARANCE; METERED DOSE INHALER; NERVOUSNESS; POLLUTANT; POWDER INHALER; SIDE EFFECT; TACHYCARDIA; TRIGGER POINT;

EID: 33751230818     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.allerg.2006.07.004     Document Type: Article

References (48)

1. Ahrens R.C. The role of the MDI and DPI in pediatric patients: "Children are not just miniature adults". Respir. Care 50 (2005) 1323-1328
2. Baraldi E., Dario C., Ongaro R., Scollo M., Azzolin N.M., Panza N., et al. Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children. Am. J. Respir. Crit. Care Med. 159 4 Pt 1 (1999) 1284-1288
3. Barbato A., Turato G., Baraldo S., Bazzan E., Calabrese F., Tura M., et al. Airway inflammation in childhood asthma. Am. J. Respir. Crit. Care Med. 168 7 (2003) 798-803
4. Bisgaard H., and Nielsen K.G. Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children. Am. J. Respir. Crit. Care Med. 162 (2000) 187-190
5. Bisgaard H., Hermansen M.N., Loland L., Halkjaer L.B., and Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N. Engl. J. Med. 354 19 (2006) 1998-2005
6. Bisgaard H., and Szefler S. Long-acting beta2 agonists and paediatric asthma. Lancet 367 (2006) 286-288
7. Bousquet J., Van Cauwenberge P., Khaltaev N., and Aria Workshop Group. World Health Organization. Allergic rhinitis and its impact on asthma. J. Allergy Clin. Immunol. 108 5 Suppl (2001) S147-S334
8. Castro-Rodriguez J.A., Holberg C.J., Wright A.L., and Martinez F.D. A clinical index to define risk of asthma in young children with recurrent wheezing. Am. J. Respir. Crit. Care Med. 162 4 Pt 1 (2000) 1403-1406
9. Chan-Yeung M., Ferguson A., Watson W., Dimich-Ward H., Rousseau R., Lilley M., et al. The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age. J. Allergy Clin. Immunol. 116 1 (2005) 49-55
10. De Benedictis F.M., and Selvaggio D. Use of inhaler devices in pediatric asthma. Paediatr. Drugs 5 (2003) 629-638
11. de Marco R., Pattaro C., Svanes F.C., and ECRHS Study Group. Influence of early life exposures and remission of asthma throughout life. J. Allergy Clin. Immunol. 113 (2004) 845-852
12. Di Rienzo V., Marcucci F., Puccinelli P., Parmiani S., Frati F., Sensi L., et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin. Exp. Allergy 33 2 (2003) 206-210
13. Delacourt C., Benoist M.R., Waernessyckle S., Rufin P., Brouard J.J., de Blic J., et al. Relationship between bronchial responsiveness and clinical evolution in infants who wheeze: a four-year prospective study. Am. J. Respir. Crit. Care Med. 164 8 (2001) 1382-1386
14. Everard M.L., Bara A., Kurian M., Elliott T.M., Ducharme F., and Mayowe V. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database Syst. Rev. 3 (2005) [CD001279]
15. Guilbert T.W., Morgan W.J., Zeiger R.S., Mauger D.T., Boehmer S.J., Szefler S.J., et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N. Engl. J. Med. 354 19 (2006) 1985-1997
16. Gustafsson D., Sjoberg O., and Foucard T. Sensitization to food and airborne allergens in children with atopic dermatitis followed up to 7 years of age. Pediatr. Allergy Immunol. 14 6 (2003) 448-452
17. Knorr B., Franchi L.M., Bisgaard H., Vermeulen J.H., LeSouef P., Santanello N., et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 108 (2001) E48
18. Lau S., Falkenhorst G., Weber A., Werthmann I., Lind P., Buettner-Goetz P., et al. High mite-allergen exposure increases the risk of sensitization in atopic children and young adults. J. Allergy Clin. Immunol. 84 (1989) 718-725
19. Lau S., Illi S., Sommerfeld C., Niggemann B., Bergmann R., von Mutius E., et al. Early exposure to house-dust mite and cat allergens and the development of childhood asthma: a cohort study. Lancet 356 (2000) 1392-1397
20. Martinez F.D., Wright A.L., Taussig L.M., Holberg C.J., Halonen M., and Morgan W.J. Asthma and wheezing in the first 6 years of life. The Group Health Medical Associates. N. Engl. J. Med. 332 (1995) 133-138
21. Martinez F.D. Safety of long-acting beta-agonists-an urgent need to clear the air. N. Engl. J. Med. 353 (2005) 2637-2639
22. Matricardi P.M., Rosmini F., Ferrigno L., Nisini R., Rapicetta M., Chionne P., et al. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 314 (1997) 999-1003
23. Moshammer H., Hoek G., Luttmann-Gibson H., Neuberger M.A., Antova T., Gehring U., et al. Parental smoking and lung function in children: an international study. Am. J. Respir. Crit. Care Med. (2006) [10.1164/rccm.200510-1552OC (epub)]
24. Noguchi E., Yokouchi Y., Zhang J., Shibuya K., Shibuya A., Bannai M., et al. Positional identification of an asthma susceptibility gene on human chromosome 5q33. Am. J. Respir. Crit. Care Med. 172 (2005) 183-188
25. Payne D.N., Rogers A.V., Adelroth E., Bandi V., Guntupalli K.K., Bush A., et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am. J. Respir. Crit. Care Med. 167 1 (2003) 78-82
26. Payne D., and Bush A. Phenotype-specific treatment of difficult asthma in children. Paediatr. Respir. Rev. 5 (2004) 116-123
27. Pajno G.B. Allergen immunotherapy in early childhood: between Scylla and Charybdis!. Clin. Exp. Allergy 35 5 (2005) 551-553
28. Perzanowski M.S., Ronmark E., Platts-Mills T.A.E., and Lundback B. Effect of cat and dog ownership on sensitization and development of asthma among preteenage children. Am. J. Respir. Crit. Care Med. 166 (2002) 696-702
29. Pohunek P., Warner J.O., Turzikova J., Kudrmann J., and Roche W.R. Markers of eosinophilic inflammation and tissue re-modelling in children before clinically diagnosed bronchial asthma. Pediatr. Allergy Immunol. 16 1 (2005) 43-51
30. Priftis K.N., Papadimitriou A., Gatsopoulou E., Yiallouros P.K., Fretzayas A., and Nicolaidou P. The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children. Eur. Respir. J. 27 2 (2006) 316-320
31. Saglani S., Malmstrom K., Pelkonen A.S., Malmberg L.P., Lindahl H., Kajosaari M., et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am. J. Respir. Crit. Care Med. 171 7 (2005) 722-727
32. Schuepp K.G., Straub D., Moller A., and Wildhaber J.H. Deposition of aerosols in infants and children. J. Aerosol Med. 17 2 (2004) 153-156
33. Sears M.R., Greene J.M., Willan A.R., Taylor D.R., Flannery E.M., Cowan J.O., et al. Long-term relation between breastfeeding and development of atopy and asthma in children and young adults: a longitudinal study. Lancet 360 (2002) 901-907
34. Sears M.R., Greene J.M., Willan A.R., Wiecek E.M., Taylor D.R., Flannery E.M., et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N. Engl. J. Med. 349 (2003) 1414-1422
35. Sheffer A.L., Silverman M., Woolcock A.J., Díaz P.V., Lindberg B., and Lindmark B. Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study. Ann. Allergy Asthma Immunol. 94 (2005) 48-54
36. Shirakawa T., Enomoto T., Shimazu S., and Hopkin J.M. The inverse association between tuberculin responses and atopic disorder. Science 275 (1997) 77-79
37. Skoner D.P., Greos L.S., Kim K.T., Roach J.M., Parsey M., and Baumgartner R.A. Evaluation of the safety and efficacy of levalbuterol in 2-5-year-old patients with asthma. Pediatr. Pulmonol. 40 (2005) 477-486
38. Sopo S.M., Macchiaiolo M., Zorzi G., and Tripodi S. Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature. Arch. Dis. Child 89 7 (2004) 620-624
39. Straub D.A., Moeller A., Minocchieri S., Hamacher J., Sennhauser F.H., Hall G.L., et al. The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma. Eur. Respir. J. 25 (2005) 289-294
40. Szefler S.J., Phillips B.R., Martinez F.D., Chinchilli V.M., Lemanske Jr. R.F., Strunk R.C., et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J. Allergy Clin. Immunol. 115 (2005) 233-242
41. Taussig L.M., Wright A.L., Holberg C.J., Halonen M., Morgan W.J., and Martinez F.D. Tucson Children's Respiratory Study: 1980 to present. J. Allergy Clin. Immunol. 111 (2003) 661-675 [quiz 676]
42. Taylor D.R. Nitric oxide as a clinical guide for asthma management. J. Allergy Clin. Immunol. 117 2 (2006) 259-262
43. Van Asperen P.P., Kemp A.S., and Mellis C.M. Skin test reactivity and clinical allergen sensitivity in infancy. J. Allergy Clin. Immunol. 73 3 (1984) 381-386
44. Walters E.H., and Walters J. Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment. Cochrane Database Syst. Rev. 2 (2003) [CD001285]
45. Verberne A.A., Frost C., Duiverman E.J., Grol M.H., and Kerrebijn K.F. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. Am. J. Respir. Crit. Care Med. 158 (1998) 213-219
46. Wark P.A., Johnston S.L., Bucchieri F., Powell R., Puddicombe S., Laza-Stanca V., et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 6 (2005) 937-947
47. Woodcock A., Lowe L.A., Murray C.S., Simpson B.M., Pipis S.D., Kissen P., et al. Early life environmental control: effect on symptoms, sensitization, and lung function at age 3 years. Am. J. Respir. Crit. Care Med. 170 4 (2004) 433-439
48. Zacharasiewicz A., Wilson N., Lex C., Erin E.M., et al. Clinical use of non-invasive measurements of airway inflammation in steroid reduction in children. Am. J. Respir. Crit. Care Med. 171 (2005) 1077-1082